Literature DB >> 15031033

HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication.

Christoph Hess1, Marcus Altfeld, Seddon Y Thomas, Marylyn M Addo, Eric S Rosenberg, Todd M Allen, Rika Draenert, Robert L Eldrige, Jan van Lunzen, Hans-J Stellbrink, Bruce D Walker, Andrew D Luster.   

Abstract

Most people infected with HIV-1 cannot control viral replication despite the presence of virus-specific CD8+ T cells. It has been postulated that this inability is related to the failure of these cells to mature into fully differentiated effector cells. We tested this hypothesis by comparing the maturation phenotype of virus-specific CD8+ T cells in people who could control viral replication off anti-retroviral therapy with those who could not. In five patients with treated acute HIV-1-infection, structured treatment interruption (STI) induced control of viral replication was associated with expansion of virus-specific CD8+ T cells with a fully differentiated effector phenotype. These effector cells were also expanded in treatment-naive chronically infected individuals who spontaneously controlled viral replication, and augmented expression of perforin was noted in both settings. Our data show that full maturation of virus-specific CD8+ T cells is possible in the context of HIV-1-infection, and suggest that such maturation might be important in viral control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031033     DOI: 10.1016/S0140-6736(04)15735-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  47 in total

1.  Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.

Authors:  Elizabeth Connick; Ronald J Bosch; Evgenia Aga; Rick Schlichtemeier; Lisa M Demeter; Paul Volberding
Journal:  J Acquir Immune Defic Syndr       Date:  2011-09-01       Impact factor: 3.731

Review 2.  The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.

Authors:  Richard A Koup; Barney S Graham; Daniel C Douek
Journal:  Nat Rev Immunol       Date:  2010-12-17       Impact factor: 53.106

3.  Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.

Authors:  Michael A Kolber
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.

Authors:  Gennadiy Zelinskyy; Shelly J Robertson; Simone Schimmer; Ronald J Messer; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire.

Authors:  Dirk Meyer-Olson; Kristen W Brady; Melissa T Bartman; Kristin M O'Sullivan; Brenna C Simons; Joseph A Conrad; Coley B Duncan; Shelly Lorey; Atif Siddique; Rika Draenert; Marylyn Addo; Marcus Altfeld; Eric Rosenberg; Todd M Allen; Bruce D Walker; Spyros A Kalams
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

6.  Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Authors:  Brenna J Hill; Patricia A Darrah; Zachary Ende; David R Ambrozak; Kylie M Quinn; Sam Darko; Emma Gostick; Linda Wooldridge; Hugo A van den Berg; Vanessa Venturi; Martin Larsen; Miles P Davenport; Robert A Seder; David A Price; Daniel C Douek
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

Review 7.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Authors:  Shawn D Blackburn; Alison Crawford; Haina Shin; Antonio Polley; Gordon J Freeman; E John Wherry
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

9.  Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.

Authors:  Julia Pohling; Katrin Zipperlen; Natasha A Hollett; Maureen E Gallant; Michael D Grant
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

10.  Sang Froid in a time of trouble: is a vaccine against HIV possible?

Authors:  Stanley A Plotkin
Journal:  J Int AIDS Soc       Date:  2009-02-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.